We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Global Blood Gas and Electrolyte Analyzers Market to Surpass USD 2.1 Billion by 2025

By LabMedica International staff writers
Posted on 06 Nov 2019
The global blood gas and electrolyte analyzers market is projected to grow at a CAGR of 6.5% during the forecast period, 2018-2025 to reach a value of over USD 2.1 billion by 2025, driven mainly by the Bench Top segment which is anticipated to bring in healthy gains and add significant momentum to the market growth. More...
The Bench Top segment is projected to grow at a CAGR of over 6.4% during the forecast period.

Geographically, several macroeconomic factors and internal market forces will shape the growth and development of demand patterns in the emerging countries in Asia-Pacific, Latin America and the Middle East. In North America, the US blood gas and electrolyte analyzers market is expected to grow at a CAGR of 5.5% during the forecast period. Within Europe, Germany is projected to add sales of over USD 64.4 million to the region’s blood gas and electrolyte analyzers market over the next 5 to 6 years. Over USD 55.9 million worth of demand in the region is projected to come from the Rest of Europe markets. In Japan, the Bench Top segment is expected to reach a market size of USD 97.6 million by the end of the forecast period.

The blood gas and electrolyte analyzers market in China, which is the world's second largest-economy and the new game changer in the global markets, is projected to grow at the rate of 9.6% over the next couple of years and add approximately USD 498.3 million in terms of addressable opportunity.



Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.